Chantal Seguin
Overview
Explore the profile of Chantal Seguin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang T, Delluc A, Cervi A, Hill D, Kovacs M, Seguin C, et al.
Thromb Res
. 2023 Nov;
233:10-13.
PMID: 37984078
No abstract available.
2.
Tanguay M, Seguin C
Res Pract Thromb Haemost
. 2022 Aug;
6(5):e12773.
PMID: 35919877
Background: Recurrent thrombosis treatment options are limited when anticoagulation with dose escalation of low molecular weight heparin or unfractionated heparin fail. Fondaparinux is a pure, synthetic pentasaccharide that consists of...
3.
Tamber G, Chevarie-Davis M, Warner M, Seguin C, Caron C, Michel R
Histopathology
. 2021 Aug;
79(6):1072-1086.
PMID: 34333806
Aims: In-situ follicular neoplasia (ISFN) occurs in approximately 2-3% of reactive lymph nodes, and is currently set apart from 'partial involvement by follicular lymphoma' (PFL). ISFN can progress to overt...
4.
Scotti P, Seguin C, Lo B, de Guise E, Troquet J, Marcoux J
J Neurosurg
. 2019 Jul;
133(2):486-495.
PMID: 31277068
Objective: Among the elderly, use of antithrombotics (ATs), antiplatelets (APs; aspirin, clopidogrel), and/or anticoagulants (ACs; warfarin, direct oral ACs [DOACs; dabigatran, rivaroxaban, apixaban]) to prevent thromboembolic events must be carefully...
5.
Wang T, Azeddine B, Mah W, Harvey E, Rosenblatt D, Seguin C
Int Orthop
. 2018 Oct;
43(3):519-530.
PMID: 30328481
Purpose: Genetic factors and hereditary forms of osteonecrosis of the femoral head (ONFH) have been elucidated through genetic association studies. The significance of these cases is that they suggest an...
6.
Marcoux S, Drouin S, Laverdiere C, Alos N, Andelfinger G, Bertout L, et al.
Pediatr Blood Cancer
. 2016 Dec;
64(6).
PMID: 27917589
Background: Childhood cancer survivorship issues represent an established public health challenge. Most late adverse effects (LAEs) have been demonstrated to be time and treatment dependent. The PETALE study is a...
7.
Carli A, Albers A, Seguin C, Harvey E
JBJS Rev
. 2016 Aug;
2(2).
PMID: 27490931
No abstract available.
8.
Mah W, Sonkusare S, Wang T, Azeddine B, Pupavac M, Carrot-Zhang J, et al.
J Med Genet
. 2016 Jun;
53(10):705-9.
PMID: 27330106
Background: Osteonecrosis of the femoral head is a debilitating disease that involves impaired blood supply to the femoral head and leads to femoral head collapse. Methods: We use whole-exome sequencing...
9.
Carli A, Harvey E, Azeddine B, Gao C, Li Y, Li A, et al.
J Orthop Res
. 2016 Feb;
35(6):1183-1194.
PMID: 26895739
Osteonecrosis of the femoral head (ONFH) is a potentially devastating complication that occurs in up to 40% of young adults receiving chronic glucocorticoid (GC) therapy. Through a validated GC therapy...
10.
Manouchehri N, Kaneva P, Seguin C, Artho G, Feldman L
Surg Endosc
. 2015 Aug;
30(5):2119-26.
PMID: 26307597
Background: Portal and/or splenic vein thrombosis (PSVT) is a potentially lethal complication of splenectomy for hematologic disease. Known risk factors for PSVT include malignancy and splenomegaly. While these patients are...